Timing of surgery after neoadjuvant chemoradiation in stage IIIA NSCLC impacts overall survival
The timing of surgery after neoadjuvant chemoradiation in patients with stage IIIA non-small cell lung cancer (NSCLC) affects the overall survival of patients receiving trimodality therapy.
Oct 6, 2016
0
0